This survey explores the impact of COVID-19 on diabetes management, revealing high concern, precautionary steps, and changes in work and daily routines.
Our April 2020 dQ&A survey of 4,700 U.S. diabetes patients finds supply chains largely intact yet short-term delays and risky pharmacy visits hinder refills.
Explore dQ&A’s First Look research on Awiqli. See real-world data from Canadian patients on once-weekly insulin for diabetes care.
